Source link : https://www.newshealth.biz/health-news/emcitate-recommended-for-peripheral-thyrotoxicosis-in-ahds/
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Emcitate (tiratricol) for treating peripheral thyrotoxicosis in patients with Allan-Herndon-Dudley syndrome (AHDS). Emcitate was designated as an orphan medicinal product for treating AHDS in 2017. The Committee for Orphan Medicinal Products will now assess whether the […]
Author : News Health
Publish date : 2024-12-13 16:35:26
Copyright for syndicated content belongs to the linked Source.
Categories